A carregar...
Bardoxolone methyl: drug development for diabetic kidney disease
Bardoxolone methyl activates the Keap1/Nrf2 system that plays an important role in defense responses against oxidative stress. Importantly, bardoxolone methyl has demonstrated increases in estimated glomerular filtration rate (eGFR) in patients with diabetic kidney disease (DKD) in clinical studies....
Na minha lista:
| Publicado no: | Clin Exp Nephrol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Singapore
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497696/ https://ncbi.nlm.nih.gov/pubmed/32594372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-020-01917-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|